Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts
Clinical trial NCT06055777 · TERMINATED
Trial details
- NCT number
- NCT06055777
- Sponsor
- Suzhou Erye Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-07
- Primary completion
- 2024-05-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.